Come up with a name for your new list and we'll add to it:
Athera Biotechnologies raised a round of funding on June 19, 2013. Investors include
Seventh Framework Programme.
Athera Biotechnologies develops a biomarker and companion diagnostic VCDefine kit. The biomaker, anti-PC, is linked to increased risk for cardiovascular disease and could in the future be used for ide…